449 related articles for article (PubMed ID: 19578865)
41. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
[TBL] [Abstract][Full Text] [Related]
42. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
Re F; Strominger JL
J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
[TBL] [Abstract][Full Text] [Related]
43. Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.
Murakami M; Gurski KJ; Marincola FM; Ackland J; Steller MA
Cancer Res; 1999 Mar; 59(6):1184-7. PubMed ID: 10096544
[TBL] [Abstract][Full Text] [Related]
44. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.
Tindle RW; Croft S; Herd K; Malcolm K; Geczy AF; Stewart T; Fernando GJ
Clin Exp Immunol; 1995 Aug; 101(2):265-71. PubMed ID: 7544248
[TBL] [Abstract][Full Text] [Related]
45. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood.
De Wit D; Tonon S; Olislagers V; Goriely S; Boutriaux M; Goldman M; Willems F
J Autoimmun; 2003 Nov; 21(3):277-81. PubMed ID: 14599853
[TBL] [Abstract][Full Text] [Related]
46. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
47. A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.
Riemer AB; Keskin DB; Zhang G; Handley M; Anderson KS; Brusic V; Reinhold B; Reinherz EL
J Biol Chem; 2010 Sep; 285(38):29608-22. PubMed ID: 20615877
[TBL] [Abstract][Full Text] [Related]
48. Influence of Human Papillomavirus E7 Oncoprotein on Maturation and Function of Plasmacytoid Dendritic Cells In Vitro.
Han R; Song YJ; Sun SY; Zhou Q; Chen XZ; Zheng QL; Cheng H
Virol Sin; 2018 Dec; 33(6):493-501. PubMed ID: 30569289
[TBL] [Abstract][Full Text] [Related]
49. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells.
Yilmaz A; Reiss C; Weng A; Cicha I; Stumpf C; Steinkasserer A; Daniel WG; Garlichs CD
J Leukoc Biol; 2006 Mar; 79(3):529-38. PubMed ID: 16387846
[TBL] [Abstract][Full Text] [Related]
51. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector.
Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R
BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563
[TBL] [Abstract][Full Text] [Related]
52. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
[TBL] [Abstract][Full Text] [Related]
53. Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.
Zhong R; Li H; Messer K; Lane TA; Zhou J; Ball ED
Cancer Immunol Immunother; 2015 Jun; 64(6):737-44. PubMed ID: 25795133
[TBL] [Abstract][Full Text] [Related]
54. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
[TBL] [Abstract][Full Text] [Related]
55. Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells.
Telepnev MV; Klimpel GR; Haithcoat J; Knirel YA; Anisimov AP; Motin VL
J Infect Dis; 2009 Dec; 200(11):1694-702. PubMed ID: 19863438
[TBL] [Abstract][Full Text] [Related]
56. Zymosan Induces Immune Responses Comparable with Those of Adults in Monocytes, Dendritic Cells, and Monocyte-Derived Dendritic Cells from Cord Blood.
Nohmi K; Tokuhara D; Tachibana D; Saito M; Sakashita Y; Nakano A; Terada H; Katayama H; Koyama M; Shintaku H
J Pediatr; 2015 Jul; 167(1):155-62.e1-2. PubMed ID: 25957979
[TBL] [Abstract][Full Text] [Related]
57. Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.
Qian J; Dong Y; Pang YY; Ibrahim R; Berzofsky JA; Schiller JT; Khleif SN
Int J Cancer; 2006 Jun; 118(12):3022-9. PubMed ID: 16425257
[TBL] [Abstract][Full Text] [Related]
58. Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients.
Ferrara A; Nonn M; Sehr P; Schreckenberger C; Pawlita M; Dürst M; Schneider A; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):521-30. PubMed ID: 12898233
[TBL] [Abstract][Full Text] [Related]
59. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
60. Dendritic cells primed with HPV positive cervical tumor lysate are superior to unprimed DCs in migratory capacity and induce a potent Th1 response.
Ramanathan P; Dhandapani H; Jayakumar H; Ganeshrajah S; Thangarajan R
Hum Immunol; 2014 Dec; 75(12):1216-24. PubMed ID: 25315748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
